DKDurga Madhab Kar

Durga Madhab Kar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Durga Madhab Kar has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    In vitro Antioxidant and Antidiabetic Activity of Solvent Extracts from Aerial Parts of Polygonum plebeium R. Br.

    by Sarojini Nayak, Durga Madhab Kar, N. Saroj Kumar Choudhury, Manoj Kumar Dalai

    This study investigated the aerial parts of Polygonum plebeium for their phytochemical composition, antioxidant potential, in vitro cytotoxicity and glucose uptake activity in yeast cells. Different solvent extracts, namely petroleum ether, chloroform, ethyl acetate, ethanol and aqueous, were evaluated. Antioxidant activity was assessed using DPPH, hydrogen peroxide scavenging and reducing power assays. HPLC analysis of the ethanol extract indicated the presence of several bioactive constituents with distinct retention times. Cytotoxicity studies on human pancreatic Min6 cells showed values of 59 ± 0.84% and 79 ± 0.78% for ethanol and ethyl acetate extracts, respectively, at 800 µg/mL. Among all tested extracts, the ethanol extract demonstrated the strongest antioxidant and antidiabetic potential. These findings suggest that the aerial parts of P. plebeium possess promising hypoglycemic activity and may serve as a potential natural source for diabetes management.

  • Exploring the Underlying Mechanism of Action of Lippia nodiflora on Wound Healing Based on Network Pharmacology, Molecular Docking, and Experimental Validation

    by Subhasish Sahoo, Om Archita Panda, Sandesh Kumar Pattanaik, Sovan Pattanaik, Asit Ray, Durga Madhab Kar, Diptirani Rath

    Lippia nodiflora leaves have been traditionally used by healers in Silent Valley, Palakkad district of Kerala, for treating wounds. This study aimed to scientifically validate the wound‐healing potential of the methanol extract of L. nodiflora leaves (MELN) to support its ethnopharmacological claims. Phytochemical profiling using UPLC–QTOF–MS identified key constituents, and network pharmacology analysis revealed potential pathways and targets involved in wound healing. These findings were further supported by molecular docking, in vitro, in vivo, and reverse transcription quantitative polymerase chain reaction (RT‐qPCR) analyses. No toxicity was observed in either in vitro or in vivo models. Network pharmacology indicated that MELN may act through the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor resistance pathway. Core compounds such as quercetin, 3‐methylherbacetin, eupafolin, 6‐hydroxyluteolin 3′‐methyl ether 7‐sulfate, and syringic acid beta‐glucopyranosyl ester likely contribute to the wound‐healing activity, as supported by docking studies. RT‐qPCR analysis demonstrated upregulation of genes related to cell migration and proliferation. In vitro assays showed enhanced cell proliferation and migration, indicating pro‐healing properties. In vivo excision wound models confirmed significant wound closure, complete epithelialization, and improved histopathological features in MELN‐treated groups. Overall, this study provides scientific evidence supporting the ethnopharmacological claim of L. nodiflora in wound management and establishes MELN as a potential herbal formulation for wound healing.


  • Open Access

    Computational prediction of gamma-oryzanol as potential agonist of human peroxisome proliferator-activated receptor gamma (ppar-γ)

    by Prasanta Kumar Biswal, Swagatika Behera, Snehamayee Mohapatra, Durga Madhab Kar, Luna Samanta, Pabitra Mohan Behera, Rajat Kumar Kar

    Diabetes mellitus is one of the complex metabolic disorders associated with individuals leading sedentary lifestyles. It leads to several complications rendering the normal function of vital organs like heart, liver, kidney, eye and brain. Scientists and doctors across the globe are involved in research for understanding the complex genetics of this disorder and formulating newer therapeutics accordingly. The finding of potential chemical entities and their underlying agonists or antagonist activities significantly controls the disorder but with some consequences. Thus there is demand for natural compounds and indigenous treatment methods for controlling the disorder with least or no adverse consequences. In the current work we present computational prediction of gamma-oryzanol as potential agonist of human peroxisome proliferator-activated receptor gamma (PPAR-γ). A group of four gamma-oryzanol compound structures reported in PubChem database were downloaded and docked in the ligand binding site of five different human PPAR-γ structures reported in PDB database. It was observed that most of the gamma-oryzanol compounds occupied themselves in the ligand binding P1, P2, P3, P4 sites with similar orientations as that of co-crystal agonists. Their binding conformations were assisted by some reasonable docking scores (−7 to -11 kcal/mol) and hydrogen bond interactions with some important conserved amino acid residues lining the ligand binding site. Additionally we have done a comparative molecular dynamics studies to reveal the flexibility of gamma-oryzanol in the ligand binding site in comparison to the co-crystal agonist and a scaffold analysis using the structure of six agonists and gamma-oryzanol for fetching potential scaffolds which may helpful in designing of new chemical entities.


  • Open Access

    Identification of bioactive constituents from different fractions of stems of Cuscuta reflexa Roxb. using GC-MS

    by Diptirani Rath, Sandeep Kumar Panigrahi, Durga Madhab Kar, Laxmidhar Maharana

    The GC-MS analysis of fractions of methanol extract of stem of Cuscuta reflexa (Family Convolvulaceae) was carried out using a THERMO TRACE 1300 Gas Chromatograph equipped and coupled to a mass detector THERMO TSQ 8000 spectrometer with an TG 5MS (30 m × 0.25 mm, 0.25 μm) of capillary column. Database of National Institute of Standards and Technology (NIST) library was used to identify the components. GC-MS revealed two known compounds i.e. 2-Methoxy-4-vinyl phenol (6.80%) and Benzofuran-2,3-dihydro (20.89%) and other 12 unknown compounds such as 3,5-di-tert-Butyl-4-hydroxyanisole (35.50%); Hexatriacontane (12.02%); n-Hexadecanoic acid (10.12%); Scoparone (7.97%); Hexadecanoic acid methyl ester (5.22%); 1,3-Benzenediamine, N, N, N′, N′ tetramethyl- (15.43%); Phenol, 4(3-hydroxy1propenyl), 2-methoxy (9.31%); Phenol, 2,4 bis (1,1dimethylethyl); 2,3,5,6-Tetramethyl para phenylene diamine (14.18%); Retinoic acid-5,6-epoxy-5,6-dihydro (20.46%); 2,4-Dihydroxy-2,5-dimethyl-3(2H)furan-3-one (10.13%); 2,3-dihydro-3,5-dihydroxy-6-methyl-2-Propyl-tetrahydro-pyran-3-ol (10.13%); Pregn-4-ene-18-oic acid (5.75%) as some of the major compounds in its different fractions. Retinoic acid-5,6-epoxy-5,6-dihydro found as major compound may be responsible for blood glucose lowering potency.